Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. MONRY
2. NYXH
3. TDY
4. PNR
5. ACN
6. ONON
7. IAUX
8. KKR
9. ORCL
10. LLY

Go back to Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure
Amgen Inc (NASDAQ: AMGN) Delayed: 393.16 --0 (-0%)
Previous Close $393.16    52 Week High $176.85 
Open $393.16    52 Week Low $133.64 
Day High $393.16    P/E 59.21 
Day Low $393.16    EPS $6.64 
Volume 2,083       

CYTOKINETICS (NASDAQ: CYTK) Delayed: 67.56 --0 (-0%)
Previous Close $67.56    52 Week High $13.18 
Open $67.56    52 Week Low $6.00 
Day High $67.56    P/E N/A 
Day Low $67.56    EPS $-1.24 
Volume 274